Established in 2017, the Physician Scientist Residency Training Award (PSRTA) is a program relatively rare in the field of urology but common in other medical and surgical fields. This award supports a three-year research training program embedded within urology residency. The focus of this program is to prepare young surgeon scientists to become successful research leaders and make impactful discoveries for their patients.
The award has two competition phases over a two-year period. First, academic institutions compete to determine which urology residency programs could provide the necessary training and support to serve as a PSRTA Program Site. Multiple institutions can be selected as PSRTA sites.
The second phase welcomes medical students participating in the urology match process to apply for an available residency slot at one of the selected institutions. One PSRTA Trainee slot is available each competition cycle.
Deadline: Feb. 29, 2024.
To be eligible to compete as a Program Site, the applicant institution must be accredited by the Liaison Committee for Medical Education (LCME), registered with the Association of American Medical Colleges (AAMC) Electronic Residency Application Service (ERAS®), and project that availability of a residency slot for use by the Physician Scientist Residency Training Award trainee. In most cases, institutions approved for this program will need to immediately apply for approval of an additional residency slot or restructuring of the residency program to accommodate the physician scientist resident candidate. Approval for any change in residency will require review by the AAMC Urology Residency Review Committee (RRC). Because this approval will require a thorough review by the RRC, institutions should be in good standing with the RRC prior to application to the Physician Scientist Residency Training Award program.